- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT02115555
Advancing Diabetes Management in Adolescents Using Health Information Technology
The study will compare three treatment strategies to look at the best clinical outcomes.
The investigator hypothesizes that the combined approach of a health information technology program plus a conflict-management contract will lead to the best outcomes.
Studieoversikt
Status
Forhold
Detaljert beskrivelse
This study will compare three strategies for enhancing adherence to diabetes care in our population. The study will look at which strategy results in the best short-term clinical outcomes for the population. Also, the study will look at patient satisfaction of contact with his/her health care team, quality of life, and family dynamics.
The three arms are:
- HIT (health information technology) aided approach
- Contracted conflict-management strategy
- Combination of the HIT-aided approach and the contracted conflict management strategy
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Indiana
-
Carmel, Indiana, Forente stater, 46032
- Riley Children's Specialties
-
Indianapolis, Indiana, Forente stater, 46202
- Riley Children's Hospital
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Type 1 diabetes diagnosed for at least 6 months
- At least one or more parent/guardian who agrees to participate
Exclusion Criteria:
- Other chronic diseases with the exception of well-controlled asthma or treated thyroid disease
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Helsetjenesteforskning
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Eksperimentell: HIT-aided approach
Adolescents and their parents randomized to this arm will be oriented on a HIT system.
The system transmits self monitoring blood glucose self monitoring blood glucose data to a secure web portal.
The subject will receive messages from the HIT system on the meter based upon the Self Monitored Blood glucose tests.
|
Subjects randomized to this approach will be using the HIT-aided monitor.
|
Eksperimentell: Contracted conflict management system
Adolescent-parent pairs will meet with a health educator to establish a behavioral contract that will set patient-centered self-management goals for the adolescent.
|
Subjects randomized to this arm will be using the behavioral contracted conflict management system.
|
Eksperimentell: HIT plus contracted conflict management
Adolescents and their parents randomized to this arm will be oriented on a HIT system.
The system transmits self monitoring blood glucose data to a secure web portal.
The subject will receive messages from the HIT system on the meter based upon the tests.
In addition, adolescent-parent pairs will meet with a health educator to establish a behavioral contract that will set patient-centered self-management goals for the adolescent.
This arm combines arms 1 and 2.
|
Subjects randomized to this arm will use both the HIT-aided approach and the behavioral contract conflict management system.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Glycemic Control using HBA1C
Tidsramme: Baseline, 3 months, and 6 months
|
Change in Glycemic Control
|
Baseline, 3 months, and 6 months
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Frequency of self monitoring blood glucose measurement
Tidsramme: Baseline, 3 months, 6 months
|
change in Self-monitoring blood glucose measurement
|
Baseline, 3 months, 6 months
|
Quality of Life
Tidsramme: Baseline and 6 months
|
Change in Diabetes-specific quality of life measures will be measured by the Varney's Pediatric Quality of Life 3.0 Diabetes Module.
|
Baseline and 6 months
|
Family dynamics
Tidsramme: Baseline and 6 months
|
Change in family dynamics measured by the Cornell Parent Behavior Description Scale and the Helping for Health Inventory.
|
Baseline and 6 months
|
Treatment Adherence Behaviors
Tidsramme: Once per month for 6 months
|
Change in treatment adherence behaviors measured by the Self-Care Inventory with supplemental questions determined by the investigator.
|
Once per month for 6 months
|
Andre resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Satisfaction
Tidsramme: 3 month and 6 month
|
Patient and parent satisfaction with the intervention with questions determined by the investigator.
|
3 month and 6 month
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Tamara Hannon, MD, Indiana University School of Medicine
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- IRB-04, IRB00000219
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Type 1 diabetes
-
Oxford Brookes UniversityUniversity of OxfordFullførtFysisk aktivitet | Mental helse velvære 1 | Kognitiv funksjon 1, sosial | Academic Attainment | Fitness TestingStorbritannia
-
IpsenAvsluttet
-
Merck Sharp & Dohme LLCRekrutteringIkke-småcellet lungekreft | Solide svulster | Programmert celledød-1 (PD1, PD-1) | Programmert celledød 1 ligand 1 (PDL1, PD-L1) | Programmert celledød 1 ligand 2 (PDL2, PD-L2)Japan
-
SanionaFullført
-
Calliditas Therapeutics ABEurofins Optimed; York Bioanalytical SolutionFullført
-
Calliditas Therapeutics ABFullført
-
Rambam Health Care CampusIsrael Science FoundationFullført
-
Alvotech Swiss AGFullført
-
PfizerFullført
-
Stony Brook UniversityFullført
Kliniske studier på HIT-aided approach
-
Nourhan M.AlyFullførtTilbakefallForente stater
-
Haukeland University HospitalRekruttering
-
Hip Innovation TechnologyRekruttering
-
Göteborg UniversitySahlgrenska University Hospital, SwedenFullført
-
University of Erlangen-Nürnberg Medical SchoolKlinikum NürnbergFullført
-
Hasselt UniversityJessa HospitalFullført
-
University of AdelaideRoyal Adelaide Hospital; University of South AustraliaAvsluttet
-
University of ZurichFullført
-
Turku University HospitalUniversity of Turku; University of Helsinki; Academy of Finland; European Foundation... og andre samarbeidspartnereUkjentType 2 diabetes mellitus | Friske FrivilligeFinland
-
Ondokuz Mayıs UniversityFullførtAnestesi, lokal | Brachial Plexus Block | NerveblokkTyrkia